We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value.
View of Banting 1 building - laboratory in Basel campus 10

Second quarter 2024 results

July 18, 2024
Basel, Switzerland

Watch the webcast
14:00 CEST | 13:00 BST | 08:00 EDT

Walkway at the entrance of the Novartis Campus in Basel, Switzerland

Investors event calendar

View recent presentations and learn more about upcoming events. 

July 18, 2024
Second quarter 2024 results
Basel, Switzerland

Group of warm clothed women, seated outside, smiling and laughing

Environmental, Social and Governance (ESG)

Novartis aims to hold itself to the highest standards of sustainability and ethical business practices. We take bold steps to increase access to medicines, tackle complex global health challenges, and do our part as a responsible corporate citizen.

ESG updates: April 2024 (PDF 1.0 MB) | February 2024 (PDF 0.6 MB) | November 2023 (PDF 1.0 MB) | August 2023 (PDF 0.3 MB)
Latest updates: Impact & Health Equity (PDF 9.9 MB) | Novartis Enterprise Risk Management (PDF 0.2 MB)  | Materiality Assessment

We have created a set of environmental, social and governance indices to signpost where our key disclosures can be found across our publications and channels. Novartis aims to report comprehensively and transparently for all stakeholders concerned with ESG topics.

Shanelle Gabriel spending time with her father in New York

Reporting and transparency hub

Read our regulatory filings; policies, codes and guidelines that govern our activities; and environmental, social and governance (ESG) disclosures.


Novartis AG
Lichtstrasse 35
CH-4056 Basel, Switzerland